| Intrinsic Valuation of: FLUOROCHEM | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 60 | Market Cap | ₹408B | |||||
| 2021 | - | - (-) | P/E Ratio | 62 | Total Asset | ₹106B | |||||
| 2022 | ₹674M | - (-) | Net Income | ₹5B | Total Debt | ₹4B | |||||
| 2023 | ₹76M | -88.8% (-92.1%) | EBITDA | ₹12B | Total Liab | ₹33B | |||||
| 2024 | ₹-3B | -4655.1% (-6176.3%) | Opr Margin | 16.16 | Debt/Equity | 0.05 | |||||
| 2025 | ₹-3B | 2.1% (11.1%) | PreTax Margin | 13.43 | BV/Share | 652 | |||||
| 5Y Average FCF | ₹-2B | 3.5% (-2085.8%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.03% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (3.5%) | ||||||||||
| 2026 | ₹388M | MBG Intrinsic Value | ₹534 | ||||||||
| 2027 | ₹400M | ||||||||||
| 2028 | ₹413M | ||||||||||
| 2029 | ₹424M | ||||||||||
| 2030 | ₹436M | ||||||||||
| 2031 | ₹447M | ||||||||||
| Terminal Value | ₹10B | Net Worth/Share | ₹664 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹9B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹551M | ₹48 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹4B | WACC | 6.5% | 44 | 50 | 58 | 69 | 83 | |||
| Equity Value | ₹5B | 7.1% | 35 | 40 | 46 | 54 | 63 | ||||
| Shares Outstanding | 109,850,000 | 7.8% | 28 | 32 | 37 | 42 | 49 | ||||
| 8.4% | 23 | 26 | 30 | 34 | 39 | ||||||
| DCF Intrinsic Value | ₹48 | 9.0% | 18 | 21 | 24 | 27 | 31 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||